Single Nucleotide Polymorphisms (SNPs) of FCγRIIA and FCγRIIIA in Patients with Diffuse Large B-Cell Lymphoma Have No Impact On Treatment Outcome of Elderly Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with CHOP with and without Rituximab: Results From the RICOVER-60 Trial of the German High-Grade Non-Hodgkin Lymhoma Study Group (DSHNHL)

被引：0
|
作者：
Ahlgrimm, Manfred
Regitz, Evi [1 ]
Preuss, Klaus-Dieter [1 ]
Grass, Sandra
Poeschel, Viola [2 ]
Kreuz, Markus [3 ]
Pfreundschuh, Michael
机构：
[1] Univ Saarland, Sch Med, Jose Carreras Ctr Immuno & Gene Therapy, Dept Internal Med 1, D-6650 Homburg, Germany
[2] DSHNHL, Homburg, Saar, Germany
[3] IMISE, Leipzig, Germany
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1521 / 1521
页数：1
相关论文
共 50 条
  • [41] Initial results of a pilot study of epratuzumab and rituximab in combination with CHOP chemotherapy (ER-CHOP) in previously untreated patients with diffuse large B-cell lymphoma (DLBCL).
    Micallef, IN
    Kahl, BS
    Gayko, U
    Cesano, A
    Ansell, SM
    Geyer, S
    Inwards, DJ
    Maurer, MJ
    Horning, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 577S - 577S
  • [42] 3 years outcome of newly diagnosed diffuse large B-cell lymphoma (DLBCL) patients treated with immunochemothrapy - Serbian lymphoma study group (SLG) experience
    Mihaljevic, B.
    Jankovic, S.
    Andjelic, B.
    Jancic-Nedeljkov, R.
    Milosevic, V.
    Sretenovic, A.
    Bogunovic, M.
    Vidovic, A.
    Todorovic, M.
    Bila, J.
    Sretenovic, M.
    Colovic, N.
    Virijevic, M.
    Markovic, O.
    Djurdjevic, P.
    Sretenovic, S.
    Jakovic, L.
    Perunicic, M.
    Petrovic, M.
    Boskovic, D.
    ANNALS OF ONCOLOGY, 2008, 19 : 221 - 221
  • [43] CNS disease in younger patients with aggressive B-cell lymphoma: an analysis of patients treated on the Mabthera International Trial and trials of the German High-Grade Non-Hodgkin Lymphoma Study Group
    Schmitz, N.
    Zeynalova, S.
    Glass, B.
    Kaiser, U.
    Cavallin-Stahl, E.
    Wolf, M.
    Haenel, M.
    Loeffler, M.
    Truemper, L.
    Pfreundschuh, M.
    ANNALS OF ONCOLOGY, 2012, 23 (05) : 1267 - 1273
  • [44] Diffuse Large B-Cell Lymphoma (DLBCL) Patients with Composite Histology Have Improved Early outcome Compared to De Novo DLBCL When Treated with R-CHOP
    Maurer, Matthew J.
    Witzig, Thomas E.
    Macon, William R.
    Syrbu, Sergei I.
    Cerhan, James R.
    Allmer, Cristine
    Johnston, Patrick B.
    Link, Brain K.
    Habermann, Thomas M.
    BLOOD, 2008, 112 (11) : 974 - 974
  • [45] Mabthera (rituximab) plus CHOP is superior to CHOP alone in elderly patients with diffuse large B-cell lymphoma (DLCL): Interim results of a randomized GELA trial.
    Coiffier, B
    Lepage, E
    Herbrecht, R
    Tilly, H
    Solal-Celigny, P
    Munck, JN
    Bouabdallah, R
    Lederlin, P
    Sebban, C
    Morel, P
    Haioun, C
    Salles, G
    Molina, T
    Gisselbrecht, C
    BLOOD, 2000, 96 (11) : 223A - 223A
  • [46] Excellent Outcome of Young Patients (18-60 years) with Favourable-Prognosis Diffuse Large B-Cell Lymphoma (DLBCL) Treated with 4 Cycles CHOP Plus 6 Applications of Rituximab: Results of the 592 Patients of the Flyer Trial of the Dshnhl/GLA
    Poeschel, Viola
    Held, Gerhard
    Ziepert, Marita
    Altmann, Bettina
    Witzens-Harig, Mathias
    Holte, Harald
    Thurner, Lorenz
    Viardot, Andreas
    Borchmann, Peter
    Kanz, Lothar
    Keller, Ulrich
    Schmidt, Christian
    Mahlberg, Rolf
    Metzner, Bernd
    Marks, Reinhard
    Hoeffkes, Heinz-Gert
    Christofyllakis, Konstantinos
    Amam, Josif
    Berdel, Christian
    Stilgenbauer, Stephan
    Schmitz, Norbert
    Truemper, Lorenz
    Murawski, Niels
    Loeffler, Markus
    Pfreundschuh, Michael
    BLOOD, 2018, 132
  • [47] The myocan phase II study of cyclophosphamide, oncovin, Myocet™ and prednisone plus rituximab (R-COMP) in elderly patients with diffuse large B-cell (DLBCL) non-Hodgkin lymphoma
    Federico, M
    Caballero, M
    Dyer, M
    Luminari, S
    Thiel, E
    ANNALS OF ONCOLOGY, 2005, 16 : 104 - 104
  • [48] High Body Mass Index (BMI) in North American Elderly Diffuse Large B-Cell Lymphoma (DLBCL) Patients Treated with Rituximab (R)-CHOP Compensates for Negative Impact of Male Gender
    Zhou, Zheng
    Rademaker, Alfred W.
    Gordon, Leo I.
    LaCasce, Ann S.
    Crosby-Thompson, Allison
    Vanderplas, Ann
    Abel, Gregory A.
    Rodriguez, Maria A.
    Nademanee, Auayporn
    Kaminski, Mark
    Czuczman, Myron S.
    Millenson, Michael M.
    Niland, Joyce
    Zelenetz, Andrew D.
    Friedberg, Jonathan W.
    Winter, Jane N.
    BLOOD, 2014, 124 (21)
  • [49] Prognostic relevance of pretreatment quality of life in diffuse large B-cell lymphoma patients treated with rituximab-CHOP: Results from a prospective cohort study
    Hyun Ae Jung
    Silvia Park
    Jin Hyun Cho
    Seonwoo Kim
    Young Hyeh Ko
    Seok Jin Kim
    Won Seog Kim
    Annals of Hematology, 2012, 91 : 1747 - 1756
  • [50] Prognostic relevance of pretreatment quality of life in diffuse large B-cell lymphoma patients treated with rituximab-CHOP: Results from a prospective cohort study
    Jung, Hyun Ae
    Park, Silvia
    Cho, Jin Hyun
    Kim, Seonwoo
    Ko, Young Hyeh
    Kim, Seok Jin
    Kim, Won Seog
    ANNALS OF HEMATOLOGY, 2012, 91 (11) : 1747 - 1756
12345